ABSI · Absci Corp
United States · RS rating 97 · As of 2026-10-14
| Price | 8.74 USD |
|---|---|
| 1-day change | -4.0% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 94 / 81 / 97 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 46 / 40 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +72.0% |
| Distance from 52-week high | +24.8% |
| Market cap (USD) | $617.1M |